Phase I SBIR grant from the National Institute of General Medical Sciences

Valitor has been awarded a Phase I SBIR grant from the National Institute of General Medical Sciences. This project is designed to investigate the use of our multivalent protein technology to accelerate wound closure for a wider set of indications related to impaired wound healing.